 Anchiano Therapeutics Ltd. ANCN the Company announced today that its board of directors approved the record date for the Companys 2020 Annual General Meeting of Shareholders the Annual Meeting to be held on or about March 23, 2020. The matters raised by Access Industries Holdings LLC and Clal Biotechnology Industries Ltd. will be addressed at the Annual Meeting. Holders of the Companys ordinary shares and holders of the Companys American Depositary Shares at the close of business on February 17, 2020, the record date, will be entitled to receive notice of, and to vote at, the Annual Meeting. 